Clinical Trial

International Chronic Myeloid Leukemia Pediatric Study

Study acronym: ICMLPed
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2011-01-20; most recent amendment 2024-01-12.
Trial Details
NCT Number NCT01281735
Lead Sponsor Poitiers University Hospital
Collaborators: CIC Inserm 1402, University of Milano Bicocca, University Medical Center Groningen, University of Liege, Imperial College London, University Hospital Dresden, International BFM Study Group
Conditions Chronic Myeloid Leukemia
Enrollment 750 participants
Start Date 2011-01
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-01-17